Clinical trial
TREatment of Triangular FibrOcaRtilage ComplEx Ruptures (REINFORCER): Protocol for Randomized, Controlled, Blinded, Efficacy Trial of Triangular Fibrocartilage Complex Tears
NCT04576169 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TREatment of Triangular FibrOcaRtilage ComplEx Ruptures (REINFORCER): Protocol for Randomized, Controlled, Blinded, Efficacy Trial of Triangular Fibrocartilage Complex Tears
- Lead sponsor
- Tampere University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 27, 2020
- Completion date
- March 31, 2035
- Enrollment
- 204 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
triangular fibrocartilage complex injury